September 2012

14 September 2012

ALTERING STATE OF AFFAIRS OF PACKAGING IN PHARMACEUTICAL INDUSTRY: A REVIEW

About Authors:
Nishant kumar gupta, *Aadesh kumar
Dept. of pharmacy BIT meerut
*adesh.adi.chaudhary@gmail.com

Abstract:
There was a point in time when packaging in pharmaceutical industry is symbolized for substantial safeguard, for identification and for merely endowing with a piece of information to any person who agree to it. But the changing scenario has been conveyed an assortment of changes, as in this day and age packaging provides the prevention of product tampering and counterfeiting, the assurance of product dispensing accuracy, child protection and the promotion of patient compliance with product dosage schedules. In the precedent time we used packaging materials, labels, holograms and some introductory communications; but these days together with them we use mobile applications, an innovative and creative unit, altering labeling standards, luxurious packaging, a packaging development team, anti-counterfeiting packaging extravaganza, hi-tech module for packaging demonstrate and an intelligent outlook. Packaging schoolwork has such an individual place in the market of counterfeit or fake drugs as nowhere. Packaging developer has an only effort to engender a special design that can competent with both fake brands and generic brand of that drug with ‘Me-too’ names.

13 September 2012

Career as Drug Safety Associate @ Icon Clinical Research

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies

13 September 2012

Career opportunity for Sales Representative in Novartis India - 4 posts

Novartis (NYSE: NVS) is a world leader in the research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.

13 September 2012

Medisynth invites applications for post of Produt Manager, Product Executive

The Medisynth Group is a self contained group, something that is unique in the homoeopathic industry. It is also among the few to maintain global standards of manufacturing in the industry.
Medisynth’s collaboration with Beck & Koll Laboratories provided the Medisynth Group with the foothold that has been maintained admirably even today. By constantly innovating and introducing newer variations, Medisynth always stays one step ahead of the rest.

13 September 2012

EFFECT OF THIODIAZURON ON MULTIPLE SHOOT INDUCTION OF DIPLOID COTTON (G. ARBOREUM CV.PA255)

About Authors:
Nitin Deorao Rewatkar
Department of Biotechnology, Kamla Nehru College,
Sakkardara Square, Nagpur
nitinrewatkar@gmail.com

Abstract
The effect of TDZ on regeneration studies of cotton G.arboreum cv PA255 was performed for in-vitro culture studies, healthy and disease free seeds, after surface sterilization were inoculated on seed germination media. Seeds germination efficiency was observed to be 73.38%. Shoot tips and cotynode explants aseptically isolated from in Vitro germinated seedlings of 7 and 14 days old were inoculated on MS basal salt supplemented with 30 gm/L glucose, 10 mg/L thiamine, 100 mg/L Inositol with four different concentration of TDZ. The proliferation of 7 and 14 days old shoot tip was found to 100% in media combination with 0.08 TDZ and 0.02 TDZ respectively. Cotynode explants of 7 days old was 100% responded in 0.02 TDZ and 0.08 TDZ, 14 days old cotynode shows highest 85% explants responded in 0.02 TDZ media combination but multiple shoots observed higher in 0.05 TDZ medium.TDZ induces callus formation and inhibit root formation, TDZ shows good responsein very small concentration otherwise increase concentration more than 1 mg/l it shows toxic effect on explants and completely dried. Browning and subsequent death of the cultured explants are major problems in TDZ supplemented media. Calculate the amount of phenol excreted from shoot tip and cotynode during in vitro regeneration of cotton cv. PA255. In the media combination 0.1mg /L TDZ evaluate highest phenol secreted, shoot tip secrete average 0.014mg and cotynode secrete 0.022mg phenol by per explants.

13 September 2012

PREPARATION AND EVALUATION OF BIODEGRADABLE ALBUMIN MICROSPHERES OF DICLOFENAC SODIUM

About Authors:
Renu^1*, Shashi Kant^2*, Rajendra Yadav³, Amit Kumar Tyagi⁴
¹Faculty of Pharmacy, Shivdan Singh Institute of Technology and Management, Aligarh (U.P)
²Jubilant Chemsys Ltd, Noida,
³Department of Pharmaceutical Sciences, Gurukul Kangri University Haridwar,
⁴Department of Chemistry, Meerut College, Meerut (U.P)
*shashi.pharma83@gmail.com

ABSTRACT :
Diclofenac is currently the eighth largest-selling drug and the most frequently used NSAID (Non-steroidal anti-inflammatory drug) in the world, since its introduction in Japan in 1974. Diclofenac is among the better tolerated NSAIDs. Only major adverse effect of Diclofenac is that it causes direct and indirect irritation of the gastrointestinal tract (GIT). To reduce the side effects on gastrointestinal tract (GIT) and to improve therapeutic efficacy of Diclofenac, it can be formulated in polymeric microspheres.
The use of polymeric carriers in formulations of therapeutic drug delivery systems has gained widespread application, due to their advantage of being biodegradable and biocompatible. Among the microparticulate systems, microspheres have a special importance since it is possible to target drugs and provide controlled release. Diclofenac sodium (DS), is a potent drug in the NSAID group having non-steroidal, anti-inflammatory properties, and is widely used in the treatment of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. In this present study, it was aimed to prepare microsphere formulations of DS using a natural biodegradable polymer as a carrier for administration to extend the duration period of the dosage form. Microsphere formulations of DS which were prepared were evaluated in vitro for particle size, yield value, encapsulation efficiency, surface morphology, and in vitro drug release.

12 September 2012

Opening For M.Sc, M.Pharm Fresher in Flamingo Pharma - 30 posts

Flamingo Pharmaceuticals Ltd. is a quality driven pharmaceutical company with an experience of over two decades in global markets, exporting to 52 countries and having Rs.200 crores+ turnover. Flamingo has WHO-GMP/UK MHRA certified 100% EOU unit.

12 September 2012

Walk in Interview for Guest Faculty in Dr B. R. Ambedkar University

The foundation of Dr B. R. Ambedkar University (originally known as Agra University) was laid on the 1st of July, 1927, as a result of hectic efforts of a band of enthusiastic educationists like Rev. Canon A.W. Davis, Munshi Narain Prasad Asthana, Dr L.P. Mathur, Lala Dewan Chand, Rai Bahadur Anand Swaroop and Dr Brajendra Swaroop,.

Submitted by admin on 12 September 2012

Forums

Clinical Research and Pharmacovigilance Forum

Job Description:

Qualifications: MBBS (with registration) & MD -Pharmacology
Certification in Clinical Research desirable

Experience : more than 1.5 year of experiience in handling the Clinical Research/ Bioequivalence studies

Knowledge of understanding & speaking in kannada language is preferred

Main Job Responsibilities :

Overall incharge of the clinical unit and the bioequivalence study related activities